Fibronectin and Extra Cellular Matrix Related Peptide | ||
Peptide Name | CAT# | Peptide Sequence |
(NMe)G-R-G-D-S-P | 1946-1-1 | Sar-Arg-Gly-Asp-Ser-Pro |
A-G-D-V | 1946-1-2 | Ala-Gly-Asp-Val |
c(Arg-Gly-Asp-DPhe-Val) | 1946-1-3 | c(Arg-Gly-Asp-DPhe-Val) |
Collagen Binding Fragment | 1946-1-4 | Cys-Gln-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr |
E-I-L-D-V, human, bovine, rat | 1946-1-5 | Glu-Ile-Leu-Asp-Val |
E-I-L-E-V-P-S-T | 1946-1-6 | Glu-Ile-Leu-Glu-Val-Pro-Ser-Thr |
Fibrinogen Beta-Chain (24-42) | 1946-1-7 | Glu-Glu-Ala-Pro-Ser-Leu-Arg-Pro-Ala-Pro-Pro-Pro-Ile-Ser-Gly-Gly-Gly-Tyr-Arg |
Fibrinogen Binding Inhibitor Peptide | 1946-1-8 | His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val |
Fibrinogen Related Peptide | 1946-1-9 | Gly-Gln-Gln-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val |
Fibrinolysis Inhibiting Factor | 1946-1-10 | Gly-Pro-Arg-Pro |
Fibrinopeptide A, human | 1946-1-11 | Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg |
Fibrinopeptide B, human | 1946-1-12 | Glp-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg |
Fibronectin Analog | 1946-1-13 | Gly-Arg-Ala-Asp-Ser-Pro-Lys |
Fibronectin CS1 Peptide | 1946-1-14 | Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr |
Fibronectin Type III Connecting Segment (1-25) | 1946-1-15 | Asp-Glu-Leu-Pro-Gln-Leu-Val-Thr-Leu-Pro-His-Pro-Asn-Leu-His-Gly-Pro-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr |
Fibronectin-Binding Protein | 1946-1-16 | Phe-Asn-Lys-His-Thr-Glu-Ile-Ile-Glu-Glu-Asp-Thr-Asn-Lys-Asp-Lys-Pro-Ser-Tyr-Gln-Phe-Gly-Gly-His-Asn-Ser-Val-Asp-Phe-Glu-Glu-Asp-Thr-Leu-Pro-Lys-Val |
G-dR-G-D-S-P | 1946-1-17 | Gly-DArg-Gly-Asp-Ser-Pro |
G-dR-G-D-S-P-A-S-S-K | 1946-1-18 | Gly-DArg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys |
G-P-R | 1946-1-19 | Gly-Pro-Arg |
G-Pen-G-R-G-D-S-P-C-A | 1946-1-20 | Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala |
G-R-A-D-S-P | 1946-1-21 | Gly-Arg-Ala-Asp-Ser-Pro |
G-R-G-D-dS-P | 1946-1-22 | Gly-Arg-Gly-Asp-DSer-Pro |
G-R-G-D-N-P | 1946-1-23 | Gly-Arg-Gly-Asp-Asn-Pro |
G-R-G-D-S | 1946-1-24 | Gly-Arg-Gly-Asp-Ser |
G-R-G-D-S-P | 1946-1-25 | Gly-Arg-Gly-Asp-Ser-Pro |
G-R-G-D-S-P-C | 1946-1-26 | Gly-Arg-Gly-Asp-Ser-Pro-Cys |
G-R-G-D-S-P-K | 1946-1-27 | Gly-Arg-Gly-Asp-Ser-Pro-Lys |
G-R-G-D-T-P | 1946-1-28 | Gly-Arg-Gly-Asp-Thr-Pro |
G-R-G-E-S | 1946-1-29 | Gly-Arg-Gly-Glu-Ser |
G-R-G-E-S-P | 1946-1-30 | Gly-Arg-Gly-Glu-Ser-Pro |
G-R-G-E-T-P | 1946-1-31 | Gly-Arg-Gly-Glu-Thr-Pro |
K-G-D-S | 1946-2-1 | Lys-Gly-Asp-Ser |
Necrofibrin, human | 1946-2-2 | Gly-Ala-Val-Ser-Thr-Ala |
Necrofibrin, rat | 1946-2-3 | Trp-Thr-Val-Pro-Thr-Ala |
Platelet Membrane Glycoprotein IIB Peptide (296-306) | 1946-2-4 | Thr-Asp-Val-Asn-Gly-Asp-Gly-Arg-His-Asp-Leu |
R-E-D-V | 1946-2-5 | Arg-Glu-Asp-Val |
R-G-D | 1946-2-6 | Arg-Gly-Asp |
R-G-D-C | 1946-2-7 | Arg-Gly-Asp-Cys |
R-G-D-S | 1946-2-8 | Arg-Gly-Asp-Ser |
R-G-D-S-P-A-S-S-K-P | 1946-2-9 | Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro |
R-G-D-T | 1946-2-10 | Arg-Gly-Asp-Thr |
R-G-D-V | 1946-2-11 | Arg-Gly-Asp-Val |
R-G-E-S | 1946-2-12 | Arg-Gly-Glu-Ser |
S-D-G-R | 1946-2-13 | Ser-Asp-Gly-Arg |
S-D-G-R-G | 1946-2-14 | Ser-Asp-Gly-Arg-Gly |
Y-R-G-D-S | 1946-2-15 | Tyr-Arg-Gly-Asp-Ser |
[Glu1] Fibrinopeptide B, human | 1946-2-16 | Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg |
[Tyr0] Fibrinopeptide A, human | 1946-2-17 | Tyr-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg |
[Tyr15] Fibrinopeptide B, human | 1946-2-18 | Glp-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-Tyr |
Company
Name: PhtdPeptides. Co.,
Ltd.
Contact: William
wang
Email: phtd012@phtdpeptides.com
Email: phtd012@phtdpeptides.com
web: www.phtdpeptides.com
Skype: william39333
Skype: william39333
QQ:329284319
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230
Tel : 0086-0371-65741695
Fax: 0086-0371-66837889
Mobile:0086-13592439230
没有评论:
发表评论